Rossignol DA - Search Results

1

Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.

Bradstreet JJ, Smith S, Baral M, Rossignol DA. Bradstreet JJ, et al. Among authors: rossignol da. Altern Med Rev. 2010 Apr;15(1):15-32. Altern Med Rev. 2010. PMID: 20359266 Review.

2

Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders.

Bradstreet JJ, Smith S, Granpeesheh D, El-Dahr JM, Rossignol D. Bradstreet JJ, et al. Med Hypotheses. 2007;68(5):979-87. doi: 10.1016/j.mehy.2006.10.015. Epub 2006 Dec 5. Med Hypotheses. 2007. PMID: 17150311

3

The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study.

Rossignol DA, Rossignol LW, James SJ, Melnyk S, Mumper E. Rossignol DA, et al. Among authors: rossignol lw. BMC Pediatr. 2007 Nov 16;7:36. doi: 10.1186/1471-2431-7-36. BMC Pediatr. 2007. PMID: 18005455 Free PMC article.

4

Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Rossignol DA, Rossignol LW, Smith S, Schneider C, Logerquist S, Usman A, Neubrander J, Madren EM, Hintz G, Grushkin B, Mumper EA. Rossignol DA, et al. Among authors: rossignol lw. BMC Pediatr. 2009 Mar 13;9:21. doi: 10.1186/1471-2431-9-21. BMC Pediatr. 2009. PMID: 19284641 Free PMC article. Clinical Trial.

5

Novel and emerging treatments for autism spectrum disorders: a systematic review.

Rossignol DA. Rossignol DA. Ann Clin Psychiatry. 2009 Oct-Dec;21(4):213-36. Ann Clin Psychiatry. 2009. PMID: 19917212 Review.

6

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Rossignol DA, Frye RE. Rossignol DA, et al. Mol Psychiatry. 2012 Mar;17(3):290-314. doi: 10.1038/mp.2010.136. Epub 2011 Jan 25. Mol Psychiatry. 2012. PMID: 21263444 Free PMC article. Review.

7

Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Frye RE, Rossignol DA. Frye RE, et al. Among authors: rossignol da. Pediatr Res. 2011 May;69(5 Pt 2):41R-7R. doi: 10.1203/PDR.0b013e318212f16b. Pediatr Res. 2011. PMID: 21289536 Free PMC article. Review.

8

Melatonin in autism spectrum disorders: a systematic review and meta-analysis.

Rossignol DA, Frye RE. Rossignol DA, et al. Dev Med Child Neurol. 2011 Sep;53(9):783-792. doi: 10.1111/j.1469-8749.2011.03980.x. Epub 2011 Apr 19. Dev Med Child Neurol. 2011. PMID: 21518346 Review.

9

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.

Rossignol DA, Frye RE. Rossignol DA, et al. Mol Psychiatry. 2012 Apr;17(4):389-401. doi: 10.1038/mp.2011.165. Epub 2011 Dec 6. Mol Psychiatry. 2012. PMID: 22143005 Free PMC article. Review.

10

Hyperbaric oxygen treatment in autism spectrum disorders.

Rossignol DA, Bradstreet JJ, Van Dyke K, Schneider C, Freedenfeld SH, O'Hara N, Cave S, Buckley JA, Mumper EA, Frye RE. Rossignol DA, et al. Med Gas Res. 2012 Jun 15;2(1):16. doi: 10.1186/2045-9912-2-16. Med Gas Res. 2012. PMID: 22703610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results